GCA and heart failure: Thus, NP analogues may not necessarily compensate for a loss of GC-1/2 function, while vice versa, sGC stimulators may not compensate for a loss of GC-A or GC-B-mediated cGMP production; a phenomenon exemplified in experimental heart failure.135